By increasing our knowledge of normal stem cells we will understand more about stem cell behaviour in tumours and this will enable us to develop novel therapeutic approaches specifically targeted at these cells.
We want to understand what determines how cells progress down the stem – progenitor – differentiated cell hierarchy, and what defines a cell at each of these stages.
